These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18597650)

  • 1. Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes.
    Makeeva O; Stepanov V; Puzyrev V; Goldstein DB; Grossman I
    Pharmacogenomics; 2008 Jul; 9(7):847-68. PubMed ID: 18597650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: A systematic review.
    Dorji PW; Tshering G; Na-Bangchang K
    J Clin Pharm Ther; 2019 Aug; 44(4):508-524. PubMed ID: 30980418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
    Zuo J; Xia D; Jia L; Guo T
    Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
    Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
    Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristic of the Genetic Variability of Four Polymorphic Variants (rs2069705, rs17880053, rs11126176, and rs804271) in Representative Samples of Indigenous and Alien Populations of Siberia].
    Kucher AN; Babushkina NP; Kulish EV; Makeeva OA; Bragina EY; Goncharova IA; Eremina ER; Puzyrev VP
    Genetika; 2015 Aug; 51(8):946-52. PubMed ID: 26601495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
    Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
    Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying drugs needing pharmacogenetic monitoring in a Korean hospital.
    Kim YM; Yoo SH; Kang RY; Kim MJ; Bae YY; Lee YK; Jeon SJ; Chon KJ; Shin SM; Kim SG; Park KH; Son IJ
    Am J Health Syst Pharm; 2007 Jan; 64(2):166-75. PubMed ID: 17215467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.
    Solus JF; Arietta BJ; Harris JR; Sexton DP; Steward JQ; McMunn C; Ihrie P; Mehall JM; Edwards TL; Dawson EP
    Pharmacogenomics; 2004 Oct; 5(7):895-931. PubMed ID: 15469410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PM frequencies of major CYPs in Asians and Caucasians.
    Mizutani T
    Drug Metab Rev; 2003; 35(2-3):99-106. PubMed ID: 12959412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population.
    Liou YH; Lin CT; Wu YJ; Wu LS
    J Hum Genet; 2006; 51(10):857. PubMed ID: 16924387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination analysis in genetic polymorphisms of drug-metabolizing enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese population.
    Ota T; Kamada Y; Hayashida M; Iwao-Koizumi K; Murata S; Kinoshita K
    Int J Med Sci; 2015; 12(1):78-82. PubMed ID: 25552922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetic differentiation of ethnic populations in Southern and Eastern Siberia based on mitochondrial DNA polymorphism].
    Derenko MV; Maliarchuk BA; Denisova GA; Dambueva IK; Kakpakov VT; Dorzhu ChM; Luzina FA; Lotosh EA; Ondar UN; Kaplina MI; Zakharov IA
    Genetika; 2002 Oct; 38(10):1409-16. PubMed ID: 12449652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 in Pharmacogenetics: An Update.
    Tornio A; Backman JT
    Adv Pharmacol; 2018; 83():3-32. PubMed ID: 29801580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population.
    Hilli J; Rane A; Lundgren S; Bertilsson L; Laine K
    Fundam Clin Pharmacol; 2007 Aug; 21(4):379-86. PubMed ID: 17635176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population.
    Krasniqi V; Dimovski A; Bytyqi HQ; Eftimov A; Šimičević L; Božina N
    Arh Hig Rada Toksikol; 2017 Sep; 68(3):180-184. PubMed ID: 28976882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset.
    Gordon AS; Tabor HK; Johnson AD; Snively BM; Assimes TL; Auer PL; Ioannidis JP; Peters U; Robinson JG; Sucheston LE; Wang D; Sotoodehnia N; Rotter JI; Psaty BM; Jackson RD; Herrington DM; O'Donnell CJ; Reiner AP; Rich SS; Rieder MJ; Bamshad MJ; Nickerson DA;
    Hum Mol Genet; 2014 Apr; 23(8):1957-63. PubMed ID: 24282029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
    Skadrić I; Stojković O
    Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased Frequencies of the -174G and -572C IL6 Alleles in Populations of Indigenous Peoples of Siberia Compared to Russians].
    Tabikhanova LE; Osipova LP; Churkina TV; Kovalev SS; Filipenko ML; Voronina EN
    Mol Biol (Mosk); 2023; 57(2):350-359. PubMed ID: 37000662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic epidemiology of pharmacogenetic variations in CYP2C9, CYP4F2 and VKORC1 genes associated with warfarin dosage in the Indian population.
    Giri AK; Khan NM; Grover S; Kaur I; Basu A; Tandon N; Scaria V; ; ; Kukreti R; Brahmachari SK; Bharadwaj D
    Pharmacogenomics; 2014 Jul; 15(10):1337-54. PubMed ID: 25155935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
    Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
    Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.